SCHEMBL14640437

SCHEMBL14640437

O=c1cc(Cl)sn1Cc1ccc(C2(c3ccccc3)OCCO2)cc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KAT2B Q92831 7/20 0.41
ALDH1A1 P00352 2/20 0.36
MAPT P10636 1/20 0.36
G6PD P11413 1/20 0.36
PKM P14618 1/20 0.36
HPGD P15428 1/20 0.36
ALOX15 P16050 1/20 0.36
HTT P42858 1/20 0.36
HSD17B10 Q99714 1/20 0.36
TDP1 Q9NUW8 1/20 0.36
CYP26A1 O43174 1/20 0.35
CYP26B1 Q9NR63 1/20 0.35
GSK3B P49841 2/20 0.35
GSK3A P49840 1/20 0.35
CASP3 P42574 1/20 0.34
ALKBH5 Q6P6C2 1/20 0.34
FAAH O00519 1/20 0.34
MGLL Q99685 1/20 0.34
RGS4 P49798 1/20 0.33
RGS8 P57771 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5604460 0.81 ALDH1A1 (0.61) KAT2BALDH1A1MAPTG6PDPKM
SCHEMBL80967 0.79 KAT2B (0.58) KAT2BALDH1A1MAPTG6PDPKM
Hydrochloric Acid SCHEMBL9517520 0.77 KAT2B (0.56) KAT2BALDH1A1MAPTG6PDPKM
SCHEMBL678175 0.72 KAT2B (0.58) KAT2BMAPTRGS4RGS8
SCHEMBL14640438 0.71 KAT2B (0.49) KAT2BALDH1A1MAPTG6PDPKM
SCHEMBL14640376 0.71 KAT2B (0.46) KAT2BALDH1A1MAPTG6PDPKM
SCHEMBL5593629 0.71 KAT2B (0.49) KAT2BALDH1A1MAPTG6PDPKM
SCHEMBL5593712 0.70 KAT2B (0.55) KAT2BALDH1A1MAPTG6PDPKM
SCHEMBL1256099 0.68 CHEK2 (0.39) ALDH1A1CYP26A1CYP26B1CHEK2
SCHEMBL16058427 0.68 TSHR (0.46) HPGDCYP26A1CYP26B1CHEK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2007001932-A2 SUBSTITUTED ISOTHIAZOLONES AS INHIBITORS OF CYTOSOLIC PHOSPHOLIPASE A2 JANSSEN PHARMACEUTICA N.V. (BE) 2007-01-04 WO disclosed